2023 - Research.com Neuroscience in Denmark Leader Award
2022 - Research.com Medicine in Denmark Leader Award
Jes Olesen mostly deals with Migraine, Anesthesia, Aura, Internal medicine and Psychiatry. Migraine with aura is the focus of his Migraine research. In general Anesthesia, his work in Cerebral blood flow is often linked to In patient linking many areas of study.
His study in Aura is interdisciplinary in nature, drawing from both Photophobia, Concordance, Magnetic resonance angiography and Headaches. In his research on the topic of Internal medicine, Calcitonin gene-related peptide is strongly related with Endocrinology. As part of his studies on Psychiatry, he often connects relevant subjects like Cost of illness.
Jes Olesen spends much of his time researching Migraine, Anesthesia, Internal medicine, Aura and Placebo. His Migraine research is within the category of Psychiatry. He studies Psychiatry, focusing on International Classification of Headache Disorders in particular.
His study looks at the relationship between Anesthesia and topics such as Middle cerebral artery, which overlap with Cerebral arteries and Transcranial Doppler. He has included themes like Endocrinology and Cardiology in his Internal medicine study. His Placebo research is multidisciplinary, incorporating perspectives in Adverse effect and Randomized controlled trial.
The scientist’s investigation covers issues in Migraine, Internal medicine, Anesthesia, Aura and Migraine with aura. The subject of his Migraine research is within the realm of Psychiatry. Jes Olesen combines subjects such as Gastroenterology, Endocrinology and Middle meningeal artery with his study of Internal medicine.
His Anesthesia study combines topics from a wide range of disciplines, such as Healthy volunteers, Placebo and Magnetic resonance angiography. His study on Aura also encompasses disciplines like
His primary scientific interests are in Migraine, Internal medicine, Anesthesia, Aura and Endocrinology. His research on Migraine concerns the broader Psychiatry. Jes Olesen works mostly in the field of Psychiatry, limiting it down to topics relating to Epidemiology and, in certain cases, Systematic search, Medication overuse and Population based, as a part of the same area of interest.
The Anesthesia study combines topics in areas such as Placebo and Asymptomatic. His Aura research includes themes of Magnetic resonance angiography, Hypoxia, CAD and Endothelial dysfunction. His work carried out in the field of Endocrinology brings together such families of science as Pathology, Vasoactive intestinal peptide, Bolus and Cyclic adenosine monophosphate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The International Classification of Headache Disorders, 3rd edition (beta version)
Jes Olesen;André Bes;Robert Kunkel;James W. Lance.
The International Classification of Headache Disorders: 2nd edition
Jes Olesen;Peter Goadsby;Tim Steiner.
Lancet Neurology (2003)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H.U. Wittchen;F. Jacobi;J. Rehm;J. Rehm;Anders Gustavsson.
European Neuropsychopharmacology (2011)
The International Classification of Headache Disorders
Epidemiology of headache in a general population—A prevalence study
Birthe Krogh Rasmussen;Rigmor Jensen;Marianne Schroll;Jes Olesen.
Journal of Clinical Epidemiology (1991)
Cost of disorders of the brain in Europe 2010
Anders Gustavsson;Mikael Svensson;Frank Jacobi;Christer Allgulander.
European Neuropsychopharmacology (2011)
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson;Dan Rujescu;Sven Cichon;Olli P. H. Pietilainen.
Common variants conferring risk of schizophrenia
Hreinn Stefansson;Hreinn Stefansson;Roel A. Ophoff;Roel A. Ophoff;Roel A. Ophoff;Stacy Steinberg;Stacy Steinberg;Ole A. Andreassen.
The economic cost of brain disorders in Europe
J Olesen;A Gustavsson;Mikael Svensson;H-U Wittchen.
European Journal of Neurology (2012)
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
Jes Olesen;Hans-Christoph Diener;Ingo W. Husstedt;Peter J. Goadsby.
The New England Journal of Medicine (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: